September 2018 marked the 20th anniversary of the World Health Organization’s report recognizing familial hypercholesterolemia (FH) as an important global public health issue.[1] FH results in life-long elevations in low density lipoprotein cholesterol and increased risk for cardiovascular disease, and affects one in 250 individuals.[2] It is among the most common inherited diseases to be encountered by clinicians; however, 20 years after the WHO’s report, FH remains underdiagnosed and undertreated in most of the world,[3] including British Columbia.[4]
Read More